Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00513123 · ClinicalTrials.gov registry record

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia

A clinical trial of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
100
Enrollment target
5
Study locations

NCT00513123: Completed study of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00513123 is a study of Cervical Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (82% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00513123, a study of Cervical Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
100 participants
Enrollment target
5
Study locations

Study Summary

The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using digital colposcopy for colposcopy for fluorescence spectroscopy. Other Objectives: * To measure digital fluorescence and reflectance images in vivo of sites in the human cervix. * To evaluate the effect of acetic acid in the image contrast obtained. * Compare the device performance to colposcopy and pathologic analysis of tissue removed at colposcopy.

Conditions Studied

Cervical Cancer

Interventions

  • PROCEDURE Colposcopy

Study Locations (5)

Texas

  • Lyndon B. Johnson Hospital - Houston
  • U.T. Health Science Center - Houston
  • U.T.M.D. Anderson Cancer Center - Houston

British Columbia

  • British Columbia Cancer Research Center - Vancouver

Oyo State

  • University College Hospital - Ibadan

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2002-09
Est. Completion 2009-02
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00513123 record still lists

NCT00513123 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which Colposcopy is the first listed.

NCT00513123 lists 5 locations in 3 states (Texas, British Columbia, Oyo State).

Frequently Asked Questions

What is clinical trial NCT00513123 about?

NCT00513123 is a clinical study titled "Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia". The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using digital colposcopy for colposcopy for fluorescence spectroscopy. Other Objectives: * To measure digital fluorescence and reflectance images i...

What is the current status of trial NCT00513123?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2002-09. Estimated completion is 2009-02.

What conditions does trial NCT00513123 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT00513123?

The interventions under investigation include: Colposcopy (PROCEDURE).

Who is sponsoring clinical trial NCT00513123?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00513123 being conducted?

This trial has 5 study locations across Texas, British Columbia, Oyo State. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00513123's enrollment target sits among peer trials

100 70th of 144 higher than 72 of 144 other Cervical Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00513123, the US trial registry maintained by the National Library of Medicine. NCT00513123 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.